Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.857 | 9.71e-16 | 3.73e-04 | 2.82e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
HCFC1 | 3054 | 40 | -2.925 | 3.449 | 71 | Yes | Yes |
MED19 | 219541 | 30 | -2.657 | 3.449 | 115 | Yes | - |
PXN | 5829 | 19 | -2.554 | 3.193 | 206 | Yes | Yes |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
APC | 324 | 13 | -2.293 | 3.004 | 353 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
ULK2 | 9706 | 9 | -2.292 | 3.197 | 312 | Yes | Yes |
ZFP36 | 7538 | 10 | -2.968 | 2.869 | 24 | Yes | Yes |
LUC7L3 | 51747 | 33 | -3.523 | 3.449 | 18 | Yes | - |
NFKB1 | 4790 | 9 | -2.123 | 2.870 | 263 | Yes | - |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
NFRKB | 4798 | 48 | -3.129 | 3.108 | 23 | Yes | Yes |
MVP | 9961 | 16 | -2.846 | 3.193 | 20 | Yes | Yes |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
[ HNRNPM ] | 4670 | 1 | -1.884 | 2.857 | 117 | - | - |
STK4 | 6789 | 3 | -2.048 | 3.110 | 228 | Yes | - |
MAP3K1 | 4214 | 3 | -2.088 | 2.975 | 123 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
SRSF3 | 6428 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
HNRNPM | 4670 | PXN | 5829 | pp | -- | int.I2D: BIND |
PXN | 5829 | MVP | 9961 | pp | -- | int.I2D: BIND |
DDIT3 | 1649 | NFKB1 | 4790 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
APC | 324 | HNRNPM | 4670 | pp | -- | int.I2D: BioGrid, SOURAV_MAPK_HIGH |
NFKB1 | 4790 | ULK2 | 9706 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
HNRNPM | 4670 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
APC | 324 | PXN | 5829 | pp | -- | int.I2D: MINT, MINT_Mouse; int.Mint: MI:0914(association) |
NFRKB | 4798 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
LUC7L3 | 51747 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
NFKB1 | 4790 | NFRKB | 4798 | pp | -- | int.I2D: BCI, HPRD; int.Ravasi: -; int.HPRD: in vitro |
PXN | 5829 | SRSF3 | 6428 | pp | -- | int.I2D: BIND |
APC | 324 | NFKB1 | 4790 | pp | -- | int.I2D: IntAct, SOURAV_MAPK_LOW |
HCFC1 | 3054 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
HNRNPM | 4670 | NFKB1 | 4790 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
SRSF3 | 6428 | ULK2 | 9706 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
HNRNPM | 4670 | STK4 | 6789 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
MAP3K1 | 4214 | HNRNPM | 4670 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
HNRNPU | 3192 | ULK2 | 9706 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
HCFC1 | 3054 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
HNRNPM | 4670 | ULK2 | 9706 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
SRSF3 | 6428 | STK4 | 6789 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
HNRNPU | 3192 | STK4 | 6789 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
NFKB1 | 4790 | ZFP36 | 7538 | pp | -- | int.I2D: BioGrid |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
DDIT3 | 1649 | HNRNPM | 4670 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0005515 | protein binding | 3.86e-06 | 5.56e-02 | 1.177 | 17 | 198 | 6024 |
GO:0042594 | response to starvation | 7.18e-06 | 1.04e-01 | 6.277 | 3 | 4 | 31 |
GO:0006366 | transcription from RNA polymerase II promoter | 8.00e-06 | 1.15e-01 | 3.520 | 6 | 30 | 419 |
GO:0005634 | nucleus | 8.84e-06 | 1.27e-01 | 1.399 | 15 | 159 | 4559 |
GO:0005654 | nucleoplasm | 2.17e-05 | 3.12e-01 | 2.567 | 8 | 64 | 1082 |
GO:0019901 | protein kinase binding | 3.37e-05 | 4.85e-01 | 3.660 | 5 | 18 | 317 |
GO:0044212 | transcription regulatory region DNA binding | 4.78e-05 | 6.90e-01 | 4.254 | 4 | 17 | 168 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.14e-04 | 1.00e+00 | 6.946 | 2 | 2 | 13 |
GO:0008380 | RNA splicing | 1.56e-04 | 1.00e+00 | 3.813 | 4 | 22 | 228 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 1.57e-04 | 1.00e+00 | 4.805 | 3 | 8 | 86 |
GO:0008134 | transcription factor binding | 1.97e-04 | 1.00e+00 | 3.727 | 4 | 18 | 242 |
GO:0035329 | hippo signaling | 4.70e-04 | 1.00e+00 | 5.946 | 2 | 5 | 26 |
GO:0006974 | cellular response to DNA damage stimulus | 8.18e-04 | 1.00e+00 | 3.993 | 3 | 7 | 151 |
GO:0000398 | mRNA splicing, via spliceosome | 1.04e-03 | 1.00e+00 | 3.874 | 3 | 15 | 164 |
GO:0010467 | gene expression | 1.09e-03 | 1.00e+00 | 2.582 | 5 | 45 | 669 |
GO:0035019 | somatic stem cell maintenance | 1.12e-03 | 1.00e+00 | 5.324 | 2 | 6 | 40 |
GO:2000016 | negative regulation of determination of dorsal identity | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0023057 | negative regulation of signaling | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0051435 | BH4 domain binding | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0072376 | protein activation cascade | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0044822 | poly(A) RNA binding | 1.31e-03 | 1.00e+00 | 2.187 | 6 | 50 | 1056 |
GO:0005829 | cytosol | 1.48e-03 | 1.00e+00 | 1.531 | 9 | 86 | 2496 |
GO:0050728 | negative regulation of inflammatory response | 2.18e-03 | 1.00e+00 | 4.839 | 2 | 3 | 56 |
GO:0060242 | contact inhibition | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:0019046 | release from viral latency | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 2 | 2 |
GO:0009786 | regulation of asymmetric cell division | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:0008013 | beta-catenin binding | 2.49e-03 | 1.00e+00 | 4.739 | 2 | 9 | 60 |
GO:0009798 | axis specification | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:0003677 | DNA binding | 2.74e-03 | 1.00e+00 | 1.981 | 6 | 49 | 1218 |
GO:0071260 | cellular response to mechanical stimulus | 2.92e-03 | 1.00e+00 | 4.624 | 2 | 4 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 2.92e-03 | 1.00e+00 | 4.624 | 2 | 4 | 65 |
GO:0034146 | toll-like receptor 5 signaling pathway | 2.92e-03 | 1.00e+00 | 4.624 | 2 | 4 | 65 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 3.47e-03 | 1.00e+00 | 4.496 | 2 | 4 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 3.47e-03 | 1.00e+00 | 4.496 | 2 | 4 | 71 |
GO:0034162 | toll-like receptor 9 signaling pathway | 3.57e-03 | 1.00e+00 | 4.476 | 2 | 4 | 72 |
GO:0003729 | mRNA binding | 3.57e-03 | 1.00e+00 | 4.476 | 2 | 4 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 3.67e-03 | 1.00e+00 | 4.456 | 2 | 4 | 73 |
GO:0060215 | primitive hemopoiesis | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0008545 | JUN kinase kinase activity | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:1900127 | positive regulation of hyaluronan biosynthetic process | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0050779 | RNA destabilization | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0033256 | I-kappaB/NF-kappaB complex | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0003157 | endocardium development | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0071013 | catalytic step 2 spliceosome | 4.18e-03 | 1.00e+00 | 4.361 | 2 | 7 | 78 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 4.39e-03 | 1.00e+00 | 4.324 | 2 | 5 | 80 |
GO:0032680 | regulation of tumor necrosis factor production | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0032375 | negative regulation of cholesterol transport | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0034273 | ATG1/UKL1 signaling complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0038127 | ERBB signaling pathway | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0010957 | negative regulation of vitamin D biosynthetic process | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0032269 | negative regulation of cellular protein metabolic process | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:2000630 | positive regulation of miRNA metabolic process | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0019887 | protein kinase regulator activity | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0070461 | SAGA-type complex | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 2 | 5 |
GO:0001714 | endodermal cell fate specification | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 2 | 5 |
GO:0019957 | C-C chemokine binding | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 2 | 5 |
GO:0010884 | positive regulation of lipid storage | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0035925 | mRNA 3'-UTR AU-rich region binding | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0048671 | negative regulation of collateral sprouting | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0034142 | toll-like receptor 4 signaling pathway | 6.26e-03 | 1.00e+00 | 4.061 | 2 | 4 | 96 |
GO:0006355 | regulation of transcription, DNA-templated | 6.27e-03 | 1.00e+00 | 2.007 | 5 | 43 | 997 |
GO:0030858 | positive regulation of epithelial cell differentiation | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 6 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 3 | 6 |
GO:0042382 | paraspeckles | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 2 | 6 |
GO:0005737 | cytoplasm | 7.54e-03 | 1.00e+00 | 1.089 | 10 | 124 | 3767 |
GO:0002224 | toll-like receptor signaling pathway | 8.00e-03 | 1.00e+00 | 3.878 | 2 | 4 | 109 |
GO:0003723 | RNA binding | 8.28e-03 | 1.00e+00 | 2.813 | 3 | 18 | 342 |
GO:0030529 | ribonucleoprotein complex | 8.43e-03 | 1.00e+00 | 3.839 | 2 | 5 | 112 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 2 | 7 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 7 |
GO:0071354 | cellular response to interleukin-6 | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 2 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 2 | 7 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 7 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 9.71e-03 | 1.00e+00 | 2.197 | 4 | 39 | 699 |
GO:0045670 | regulation of osteoclast differentiation | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 2 | 8 |
GO:0001955 | blood vessel maturation | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 8 |
GO:0071316 | cellular response to nicotine | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 8 |
GO:0043254 | regulation of protein complex assembly | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 8 |
GO:0007172 | signal complex assembly | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 8 |
GO:0060396 | growth hormone receptor signaling pathway | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 8 |
GO:0007050 | cell cycle arrest | 1.03e-02 | 1.00e+00 | 3.692 | 2 | 5 | 124 |
GO:0030027 | lamellipodium | 1.04e-02 | 1.00e+00 | 3.680 | 2 | 7 | 125 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.09e-02 | 1.00e+00 | 3.646 | 2 | 11 | 128 |
GO:0045667 | regulation of osteoblast differentiation | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 1 | 9 |
GO:0031953 | negative regulation of protein autophosphorylation | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 1 | 9 |
GO:0000975 | regulatory region DNA binding | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 2 | 9 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 5 | 9 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 5 | 9 |
GO:0097284 | hepatocyte apoptotic process | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 1 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 5 | 9 |
GO:0035278 | negative regulation of translation involved in gene silencing by miRNA | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 1 | 9 |
GO:0048188 | Set1C/COMPASS complex | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 4 | 9 |
GO:0006983 | ER overload response | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 1 | 9 |
GO:0003382 | epithelial cell morphogenesis | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 1 | 9 |
GO:0005730 | nucleolus | 1.19e-02 | 1.00e+00 | 1.551 | 6 | 66 | 1641 |
GO:0031274 | positive regulation of pseudopodium assembly | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 10 |
GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 10 |
GO:0035413 | positive regulation of catenin import into nucleus | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 10 |
GO:0061029 | eyelid development in camera-type eye | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 10 |
GO:0001841 | neural tube formation | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 10 |
GO:0030877 | beta-catenin destruction complex | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 10 |
GO:0051010 | microtubule plus-end binding | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 3 | 11 |
GO:0017166 | vinculin binding | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 11 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 2 | 11 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 2 | 11 |
GO:0031116 | positive regulation of microtubule polymerization | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 11 |
GO:0046621 | negative regulation of organ growth | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 4 | 11 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.47e-02 | 1.00e+00 | 2.022 | 4 | 41 | 789 |
GO:0032886 | regulation of microtubule-based process | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 12 |
GO:0006402 | mRNA catabolic process | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 12 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 3 | 12 |
GO:0045295 | gamma-catenin binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 12 |
GO:0034045 | pre-autophagosomal structure membrane | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 12 |
GO:0035198 | miRNA binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 13 |
GO:0046688 | response to copper ion | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 13 |
GO:0044295 | axonal growth cone | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 13 |
GO:0043409 | negative regulation of MAPK cascade | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 2 | 13 |
GO:0046777 | protein autophosphorylation | 1.63e-02 | 1.00e+00 | 3.342 | 2 | 4 | 158 |
GO:0010744 | positive regulation of macrophage derived foam cell differentiation | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 14 |
GO:0035371 | microtubule plus-end | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 14 |
GO:0005685 | U1 snRNP | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 14 |
GO:0031011 | Ino80 complex | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 6 | 14 |
GO:0031293 | membrane protein intracellular domain proteolysis | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 14 |
GO:0017091 | AU-rich element binding | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 14 |
GO:0034614 | cellular response to reactive oxygen species | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 14 |
GO:0071375 | cellular response to peptide hormone stimulus | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 14 |
GO:0043539 | protein serine/threonine kinase activator activity | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 14 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 1.83e-02 | 1.00e+00 | 3.254 | 2 | 5 | 168 |
GO:0043981 | histone H4-K5 acetylation | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 5 | 15 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 3 | 15 |
GO:0001824 | blastocyst development | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 2 | 15 |
GO:0043982 | histone H4-K8 acetylation | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 5 | 15 |
GO:0006376 | mRNA splice site selection | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 1 | 15 |
GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 1 | 15 |
GO:0016607 | nuclear speck | 1.91e-02 | 1.00e+00 | 3.220 | 2 | 12 | 172 |
GO:0007026 | negative regulation of microtubule depolymerization | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 16 |
GO:0043274 | phospholipase binding | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 16 |
GO:0051276 | chromosome organization | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 16 |
GO:0045638 | negative regulation of myeloid cell differentiation | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 16 |
GO:0003714 | transcription corepressor activity | 2.04e-02 | 1.00e+00 | 3.170 | 2 | 11 | 178 |
GO:0071889 | 14-3-3 protein binding | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 2 | 18 |
GO:0031122 | cytoplasmic microtubule organization | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 18 |
GO:0004709 | MAP kinase kinase kinase activity | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 2 | 18 |
GO:0043984 | histone H4-K16 acetylation | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 5 | 19 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 2 | 19 |
GO:0032757 | positive regulation of interleukin-8 production | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 1 | 20 |
GO:0048675 | axon extension | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 2 | 21 |
GO:0048041 | focal adhesion assembly | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 1 | 21 |
GO:0000123 | histone acetyltransferase complex | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 6 | 21 |
GO:0009954 | proximal/distal pattern formation | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 1 | 21 |
GO:0008637 | apoptotic mitochondrial changes | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 2 | 21 |
GO:0000281 | mitotic cytokinesis | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 2 | 21 |
GO:0045787 | positive regulation of cell cycle | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 4 | 22 |
GO:0010506 | regulation of autophagy | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 2 | 23 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 1 | 23 |
GO:0045296 | cadherin binding | 2.95e-02 | 1.00e+00 | 5.061 | 1 | 3 | 24 |
GO:0006915 | apoptotic process | 3.01e-02 | 1.00e+00 | 2.115 | 3 | 12 | 555 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 3 | 25 |
GO:0000045 | autophagic vacuole assembly | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 2 | 26 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 3 | 26 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 2 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 1 | 26 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.22e-02 | 1.00e+00 | 2.076 | 3 | 37 | 570 |
GO:0048754 | branching morphogenesis of an epithelial tube | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 27 |
GO:0071339 | MLL1 complex | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 6 | 27 |
GO:0005875 | microtubule associated complex | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 1 | 28 |
GO:0003727 | single-stranded RNA binding | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 2 | 28 |
GO:0070830 | tight junction assembly | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 1 | 28 |
GO:0003713 | transcription coactivator activity | 3.46e-02 | 1.00e+00 | 2.757 | 2 | 24 | 237 |
GO:0005913 | cell-cell adherens junction | 3.56e-02 | 1.00e+00 | 4.788 | 1 | 3 | 29 |
GO:0030032 | lamellipodium assembly | 3.56e-02 | 1.00e+00 | 4.788 | 1 | 1 | 29 |
GO:0010494 | cytoplasmic stress granule | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 2 | 30 |
GO:0009953 | dorsal/ventral pattern formation | 3.80e-02 | 1.00e+00 | 4.692 | 1 | 2 | 31 |
GO:0001569 | patterning of blood vessels | 3.80e-02 | 1.00e+00 | 4.692 | 1 | 1 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 3.80e-02 | 1.00e+00 | 4.692 | 1 | 3 | 31 |
GO:0071347 | cellular response to interleukin-1 | 3.80e-02 | 1.00e+00 | 4.692 | 1 | 2 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 2 | 32 |
GO:0045600 | positive regulation of fat cell differentiation | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 2 | 32 |
GO:0033077 | T cell differentiation in thymus | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 1 | 33 |
GO:0031072 | heat shock protein binding | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 2 | 33 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 8 | 33 |
GO:0000166 | nucleotide binding | 4.07e-02 | 1.00e+00 | 2.629 | 2 | 13 | 259 |
GO:0030838 | positive regulation of actin filament polymerization | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 1 | 34 |
GO:0016592 | mediator complex | 4.28e-02 | 1.00e+00 | 4.517 | 1 | 10 | 35 |
GO:0001942 | hair follicle development | 4.28e-02 | 1.00e+00 | 4.517 | 1 | 2 | 35 |
GO:0043065 | positive regulation of apoptotic process | 4.33e-02 | 1.00e+00 | 2.580 | 2 | 7 | 268 |
GO:0007257 | activation of JUN kinase activity | 4.40e-02 | 1.00e+00 | 4.476 | 1 | 5 | 36 |
GO:0034446 | substrate adhesion-dependent cell spreading | 4.40e-02 | 1.00e+00 | 4.476 | 1 | 2 | 36 |
GO:0048538 | thymus development | 4.40e-02 | 1.00e+00 | 4.476 | 1 | 2 | 36 |
GO:0006954 | inflammatory response | 4.59e-02 | 1.00e+00 | 2.532 | 2 | 6 | 277 |
GO:0032092 | positive regulation of protein binding | 4.64e-02 | 1.00e+00 | 4.398 | 1 | 2 | 38 |
GO:0051781 | positive regulation of cell division | 4.76e-02 | 1.00e+00 | 4.361 | 1 | 1 | 39 |
GO:0005881 | cytoplasmic microtubule | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 1 | 40 |
GO:0045785 | positive regulation of cell adhesion | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 2 | 40 |
GO:0031124 | mRNA 3'-end processing | 5.12e-02 | 1.00e+00 | 4.254 | 1 | 2 | 42 |
GO:0035556 | intracellular signal transduction | 5.39e-02 | 1.00e+00 | 2.403 | 2 | 9 | 303 |
GO:0006369 | termination of RNA polymerase II transcription | 5.47e-02 | 1.00e+00 | 4.154 | 1 | 2 | 45 |
GO:0004674 | protein serine/threonine kinase activity | 5.55e-02 | 1.00e+00 | 2.379 | 2 | 6 | 308 |
GO:0016328 | lateral plasma membrane | 5.59e-02 | 1.00e+00 | 4.123 | 1 | 3 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 5.59e-02 | 1.00e+00 | 4.123 | 1 | 4 | 46 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 2 | 47 |
GO:0030216 | keratinocyte differentiation | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 2 | 47 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 3 | 48 |
GO:0000902 | cell morphogenesis | 5.95e-02 | 1.00e+00 | 4.031 | 1 | 4 | 49 |
GO:0006986 | response to unfolded protein | 6.06e-02 | 1.00e+00 | 4.002 | 1 | 4 | 50 |
GO:0030334 | regulation of cell migration | 6.06e-02 | 1.00e+00 | 4.002 | 1 | 5 | 50 |
GO:0045732 | positive regulation of protein catabolic process | 6.06e-02 | 1.00e+00 | 4.002 | 1 | 1 | 50 |
GO:0060041 | retina development in camera-type eye | 6.18e-02 | 1.00e+00 | 3.974 | 1 | 2 | 51 |
GO:0034976 | response to endoplasmic reticulum stress | 6.18e-02 | 1.00e+00 | 3.974 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 6.18e-02 | 1.00e+00 | 3.974 | 1 | 1 | 51 |
GO:0008283 | cell proliferation | 6.21e-02 | 1.00e+00 | 2.289 | 2 | 14 | 328 |
GO:0051028 | mRNA transport | 6.30e-02 | 1.00e+00 | 3.946 | 1 | 4 | 52 |
GO:0009611 | response to wounding | 6.30e-02 | 1.00e+00 | 3.946 | 1 | 5 | 52 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 4 | 53 |
GO:0000186 | activation of MAPKK activity | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 2 | 54 |
GO:0001725 | stress fiber | 6.65e-02 | 1.00e+00 | 3.865 | 1 | 4 | 55 |
GO:0043565 | sequence-specific DNA binding | 6.82e-02 | 1.00e+00 | 2.212 | 2 | 11 | 346 |
GO:0005643 | nuclear pore | 6.88e-02 | 1.00e+00 | 3.813 | 1 | 11 | 57 |
GO:0008285 | negative regulation of cell proliferation | 7.06e-02 | 1.00e+00 | 2.183 | 2 | 10 | 353 |
GO:0006396 | RNA processing | 7.12e-02 | 1.00e+00 | 3.764 | 1 | 5 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 7.12e-02 | 1.00e+00 | 3.764 | 1 | 6 | 59 |
GO:0005524 | ATP binding | 7.21e-02 | 1.00e+00 | 1.304 | 4 | 31 | 1298 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 7.35e-02 | 1.00e+00 | 3.715 | 1 | 2 | 61 |
GO:0032481 | positive regulation of type I interferon production | 7.35e-02 | 1.00e+00 | 3.715 | 1 | 6 | 61 |
GO:0006406 | mRNA export from nucleus | 7.35e-02 | 1.00e+00 | 3.715 | 1 | 4 | 61 |
GO:0019903 | protein phosphatase binding | 7.47e-02 | 1.00e+00 | 3.692 | 1 | 2 | 62 |
GO:0005925 | focal adhesion | 7.52e-02 | 1.00e+00 | 2.130 | 2 | 9 | 366 |
GO:0000776 | kinetochore | 7.58e-02 | 1.00e+00 | 3.669 | 1 | 5 | 63 |
GO:0007155 | cell adhesion | 7.63e-02 | 1.00e+00 | 2.119 | 2 | 5 | 369 |
GO:0042060 | wound healing | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 2 | 64 |
GO:0006310 | DNA recombination | 7.81e-02 | 1.00e+00 | 3.624 | 1 | 7 | 65 |
GO:0007409 | axonogenesis | 7.81e-02 | 1.00e+00 | 3.624 | 1 | 2 | 65 |
GO:0010468 | regulation of gene expression | 8.16e-02 | 1.00e+00 | 3.559 | 1 | 2 | 68 |
GO:0034329 | cell junction assembly | 8.16e-02 | 1.00e+00 | 3.559 | 1 | 3 | 68 |
GO:0018105 | peptidyl-serine phosphorylation | 8.27e-02 | 1.00e+00 | 3.538 | 1 | 2 | 69 |
GO:0032587 | ruffle membrane | 8.39e-02 | 1.00e+00 | 3.517 | 1 | 3 | 70 |
GO:0002020 | protease binding | 8.85e-02 | 1.00e+00 | 3.437 | 1 | 6 | 74 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 8.85e-02 | 1.00e+00 | 3.437 | 1 | 4 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 8.96e-02 | 1.00e+00 | 3.417 | 1 | 1 | 75 |
GO:0060070 | canonical Wnt signaling pathway | 8.96e-02 | 1.00e+00 | 3.417 | 1 | 4 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 9.08e-02 | 1.00e+00 | 3.398 | 1 | 3 | 76 |
GO:0001822 | kidney development | 9.30e-02 | 1.00e+00 | 3.361 | 1 | 3 | 78 |
GO:0007229 | integrin-mediated signaling pathway | 9.30e-02 | 1.00e+00 | 3.361 | 1 | 3 | 78 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 9.30e-02 | 1.00e+00 | 3.361 | 1 | 3 | 78 |
GO:0034138 | toll-like receptor 3 signaling pathway | 9.42e-02 | 1.00e+00 | 3.342 | 1 | 3 | 79 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 9.42e-02 | 1.00e+00 | 3.342 | 1 | 2 | 79 |
GO:0071222 | cellular response to lipopolysaccharide | 9.65e-02 | 1.00e+00 | 3.306 | 1 | 4 | 81 |
GO:0009653 | anatomical structure morphogenesis | 9.87e-02 | 1.00e+00 | 3.271 | 1 | 2 | 83 |
GO:0009952 | anterior/posterior pattern specification | 9.87e-02 | 1.00e+00 | 3.271 | 1 | 4 | 83 |
GO:0005681 | spliceosomal complex | 9.87e-02 | 1.00e+00 | 3.271 | 1 | 3 | 83 |
GO:0007165 | signal transduction | 1.00e-01 | 1.00e+00 | 1.406 | 3 | 13 | 907 |
GO:0050852 | T cell receptor signaling pathway | 1.01e-01 | 1.00e+00 | 3.237 | 1 | 2 | 85 |
GO:0005923 | tight junction | 1.02e-01 | 1.00e+00 | 3.220 | 1 | 2 | 86 |
GO:0003690 | double-stranded DNA binding | 1.02e-01 | 1.00e+00 | 3.220 | 1 | 3 | 86 |
GO:0006979 | response to oxidative stress | 1.03e-01 | 1.00e+00 | 3.203 | 1 | 6 | 87 |
GO:0006936 | muscle contraction | 1.03e-01 | 1.00e+00 | 3.203 | 1 | 3 | 87 |
GO:0050821 | protein stabilization | 1.04e-01 | 1.00e+00 | 3.187 | 1 | 3 | 88 |
GO:0000187 | activation of MAPK activity | 1.07e-01 | 1.00e+00 | 3.154 | 1 | 3 | 90 |
GO:0016363 | nuclear matrix | 1.08e-01 | 1.00e+00 | 3.138 | 1 | 6 | 91 |
GO:0007010 | cytoskeleton organization | 1.08e-01 | 1.00e+00 | 3.138 | 1 | 4 | 91 |
GO:0006928 | cellular component movement | 1.08e-01 | 1.00e+00 | 3.138 | 1 | 3 | 91 |
GO:0001649 | osteoblast differentiation | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 5 | 92 |
GO:0005770 | late endosome | 1.10e-01 | 1.00e+00 | 3.107 | 1 | 2 | 93 |
GO:0006468 | protein phosphorylation | 1.11e-01 | 1.00e+00 | 1.801 | 2 | 10 | 460 |
GO:0007417 | central nervous system development | 1.13e-01 | 1.00e+00 | 3.061 | 1 | 5 | 96 |
GO:0005178 | integrin binding | 1.13e-01 | 1.00e+00 | 3.061 | 1 | 4 | 96 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.18e-01 | 1.00e+00 | 1.745 | 2 | 24 | 478 |
GO:0030659 | cytoplasmic vesicle membrane | 1.19e-01 | 1.00e+00 | 2.988 | 1 | 2 | 101 |
GO:0008360 | regulation of cell shape | 1.21e-01 | 1.00e+00 | 2.960 | 1 | 4 | 103 |
GO:0042802 | identical protein binding | 1.21e-01 | 1.00e+00 | 1.727 | 2 | 19 | 484 |
GO:0005938 | cell cortex | 1.22e-01 | 1.00e+00 | 2.946 | 1 | 5 | 104 |
GO:0006461 | protein complex assembly | 1.30e-01 | 1.00e+00 | 2.852 | 1 | 4 | 111 |
GO:0046983 | protein dimerization activity | 1.38e-01 | 1.00e+00 | 2.764 | 1 | 5 | 118 |
GO:0006325 | chromatin organization | 1.38e-01 | 1.00e+00 | 2.764 | 1 | 12 | 118 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.44e-01 | 1.00e+00 | 2.692 | 1 | 5 | 124 |
GO:0030335 | positive regulation of cell migration | 1.47e-01 | 1.00e+00 | 2.657 | 1 | 5 | 127 |
GO:0016477 | cell migration | 1.48e-01 | 1.00e+00 | 2.646 | 1 | 4 | 128 |
GO:0016020 | membrane | 1.50e-01 | 1.00e+00 | 0.931 | 4 | 46 | 1681 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 1.53e-01 | 1.00e+00 | 2.602 | 1 | 4 | 132 |
GO:0016055 | Wnt signaling pathway | 1.59e-01 | 1.00e+00 | 2.538 | 1 | 4 | 138 |
GO:0010628 | positive regulation of gene expression | 1.67e-01 | 1.00e+00 | 2.456 | 1 | 7 | 146 |
GO:0008017 | microtubule binding | 1.68e-01 | 1.00e+00 | 2.446 | 1 | 2 | 147 |
GO:0042803 | protein homodimerization activity | 1.69e-01 | 1.00e+00 | 1.429 | 2 | 19 | 595 |
GO:0045087 | innate immune response | 1.69e-01 | 1.00e+00 | 1.427 | 2 | 15 | 596 |
GO:0031012 | extracellular matrix | 1.76e-01 | 1.00e+00 | 2.379 | 1 | 6 | 154 |
GO:0000287 | magnesium ion binding | 1.86e-01 | 1.00e+00 | 2.289 | 1 | 4 | 164 |
GO:0007049 | cell cycle | 1.96e-01 | 1.00e+00 | 2.203 | 1 | 6 | 174 |
GO:0005667 | transcription factor complex | 1.97e-01 | 1.00e+00 | 2.195 | 1 | 17 | 175 |
GO:0004672 | protein kinase activity | 1.99e-01 | 1.00e+00 | 2.179 | 1 | 3 | 177 |
GO:0031625 | ubiquitin protein ligase binding | 2.00e-01 | 1.00e+00 | 2.170 | 1 | 5 | 178 |
GO:0019904 | protein domain specific binding | 2.01e-01 | 1.00e+00 | 2.162 | 1 | 8 | 179 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.06e-01 | 1.00e+00 | 2.123 | 1 | 22 | 184 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 2.11e-01 | 1.00e+00 | 2.084 | 1 | 5 | 189 |
GO:0016071 | mRNA metabolic process | 2.45e-01 | 1.00e+00 | 1.845 | 1 | 8 | 223 |
GO:0043025 | neuronal cell body | 2.66e-01 | 1.00e+00 | 1.710 | 1 | 9 | 245 |
GO:0016070 | RNA metabolic process | 2.67e-01 | 1.00e+00 | 1.698 | 1 | 8 | 247 |
GO:0006281 | DNA repair | 2.80e-01 | 1.00e+00 | 1.618 | 1 | 14 | 261 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.83e-01 | 1.00e+00 | 1.602 | 1 | 23 | 264 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.88e-01 | 1.00e+00 | 1.575 | 1 | 7 | 269 |
GO:0005856 | cytoskeleton | 3.07e-01 | 1.00e+00 | 1.461 | 1 | 9 | 291 |
GO:0005813 | centrosome | 3.38e-01 | 1.00e+00 | 1.297 | 1 | 7 | 326 |
GO:0003682 | chromatin binding | 3.38e-01 | 1.00e+00 | 1.293 | 1 | 19 | 327 |
GO:0015031 | protein transport | 3.50e-01 | 1.00e+00 | 1.233 | 1 | 11 | 341 |
GO:0008270 | zinc ion binding | 3.56e-01 | 1.00e+00 | 0.685 | 2 | 27 | 997 |
GO:0005739 | mitochondrion | 3.57e-01 | 1.00e+00 | 0.683 | 2 | 23 | 998 |
GO:0046982 | protein heterodimerization activity | 3.82e-01 | 1.00e+00 | 1.076 | 1 | 8 | 380 |
GO:0009986 | cell surface | 3.99e-01 | 1.00e+00 | 0.995 | 1 | 9 | 402 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.07e-01 | 1.00e+00 | 0.956 | 1 | 24 | 413 |
GO:0043066 | negative regulation of apoptotic process | 4.16e-01 | 1.00e+00 | 0.918 | 1 | 16 | 424 |
GO:0044267 | cellular protein metabolic process | 4.52e-01 | 1.00e+00 | 0.757 | 1 | 20 | 474 |
GO:0048471 | perinuclear region of cytoplasm | 4.72e-01 | 1.00e+00 | 0.675 | 1 | 8 | 502 |
GO:0005886 | plasma membrane | 6.50e-01 | 1.00e+00 | -0.103 | 3 | 49 | 2582 |
GO:0005887 | integral component of plasma membrane | 6.82e-01 | 1.00e+00 | -0.148 | 1 | 10 | 888 |
GO:0046872 | metal ion binding | 8.19e-01 | 1.00e+00 | -0.706 | 1 | 29 | 1307 |
GO:0070062 | extracellular vesicular exosome | 8.27e-01 | 1.00e+00 | -0.583 | 2 | 57 | 2400 |